homocysteine has been researched along with pentoxifylline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiatt, WR; Regensteiner, JG | 1 |
| Akdemir, I; Erol, FS; Gursu, F; Kaplan, M; Kilic, N; Tiftikci, M; Topsakal, C | 1 |
1 review(s) available for homocysteine and pentoxifylline
| Article | Year |
|---|---|
Current medical therapies for patients with peripheral arterial disease: a critical review.
Topics: Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Cardiovascular Diseases; Cilostazol; Diabetes Mellitus; Estrogens; Exercise; Homocysteine; Humans; Hyperlipidemias; Hypertension; Intermittent Claudication; Meta-Analysis as Topic; Myocardial Ischemia; Pentoxifylline; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Smoking; Tetrazoles | 2002 |
1 other study(ies) available for homocysteine and pentoxifylline
| Article | Year |
|---|---|
Medroxyprogesterone acetate, enoxaparin and pentoxyfylline cause alterations in lipid peroxidation, paraoxonase (PON1) activities and homocysteine levels in the acute oxidative stress in an experimental model of spinal cord injury.
Topics: Animals; Antioxidants; Enoxaparin; Homocysteine; Lipid Peroxidation; Male; Medroxyprogesterone Acetate; Oxidative Stress; Pentoxifylline; Rats; Rats, Wistar; Spinal Cord; Spinal Cord Compression; Spinal Cord Injuries; Spinal Cord Ischemia | 2002 |